Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -6.18-66.140.2217.80-9.90

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is -6.18 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-6.18
Mar2023-66.14
Mar20220.22
Mar202117.80
Mar2020-9.90

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22
-98.76
Mar2021 17.8
Positive
Mar2020 -9.9 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹43,540.6 Cr 1.5% 17.6% 54.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,706.0 Cr 2.3% 11.7% 5.1% Stock Analytics
DIVIS LABORATORIES ₹152,946.0 Cr -1.6% 4% 58.7% Stock Analytics
CIPLA ₹120,751.0 Cr 0.8% 6.2% -2.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,988.0 Cr 0.7% 9.8% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,066.7 Cr -1% 2.8% -8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.5%

17.6%

54.5%

SENSEX

-1.3%

4.2%

3.6%


You may also like the below Video Courses